Gastrodin, AT1 Signaling, and Reactive Astrocytes
2026-09-08
The 2024 reference study identifies a microglia-to-astrocyte mechanism in which gastrodin alters renin–angiotensin system–SIRT3 signaling, inflammatory markers, and neurotrophic factors in reactive astrocytes. Its conditioned-medium design and AT1-receptor perturbation provide a useful framework for studying how microglial activation reshapes astrocyte phenotypes, while also highlighting the limits of translating an in vitro CNS model to therapeutic conclusions.
BOP Reagent for Prodrug-Oriented Peptide Chemistry
2026-09-07
BOP reagent streamlines carboxyl group activation for amide bond formation, phenyl ester preparation, and blocked amino acid derivative workflows. This guide connects practical coupling controls with assay design inspired by a carrier-free, ROS-responsive triterpene prodrug study, while clearly separating demonstrated findings from experimental extensions.
Eclipta–Barley Extracts in Danazol Puberty Models
2026-09-05
This 2025 study evaluated an Eclipta prostrata–Hordeum vulgare extract complex in rat models of precocious puberty induced by Danazol or a high-fat diet. The intervention delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation without altering body weight, supporting further investigation of botanical modulation of the hypothalamic–pituitary–gonadal axis.
Resiniferatoxin and TRPV1-Positive Afferents
2026-09-05
Szallasi’s 2023 review presents Resiniferatoxin (RTX) as a precision approach for functionally silencing TRPV1-positive sensory afferents through sustained channel activation, calcium loading, desensitization, and, in selected settings, neuronal ablation. Its analysis connects molecular pharmacology with preclinical, veterinary, and clinical research involving bladder overactivity, osteoarthritis pain, cancer pain, and other localized pain states.
BAPTA-AM Protocol and QC Guide
2026-09-04
BAPTA-AM is a cell-permeable calcium chelator for experimentally buffering intracellular Ca²⁺ in live-cell, calcium imaging, apoptosis, and ion-channel workflows. It should be optimized with vehicle and calcium-response controls, and used cautiously when magnesium sensitivity, potassium-channel activity, or nonspecific solvent effects could confound interpretation.
Linezolid: A Mechanism-Aware Assay Guide
2026-09-04
Linezolid is an oxazolidinone antimicrobial best understood through the assay readouts it controls, not only its pathogen spectrum. This guide connects ribosomal initiation assays with resistance-oriented workflows and the distinct MmpL3 discovery strategy reported for spirocyclic POM analogues.
Bromodomain Inhibitor (+)-JQ1 in AR-Heterogeneous PCa
2026-09-03
Discover how the BET bromodomain inhibitor (+)-JQ1 can be used to interrogate treatment response in androgen receptor-heterogeneous prostate cancer. This article connects chromatin-reader inhibition with state-resolved apoptosis assays, resistance biology, and cross-domain translational research.
NAD+: A Practical Assay Guide
2026-09-03
This scenario-based guide explains how Nicotinamide Adenine Dinucleotide (NAD+) (SKU B1793) can support reproducible metabolic, viability, proliferation, and cellular-stress experiments. It covers assay interpretation, solvent compatibility, protocol design, mechanistic controls, and practical vendor selection without treating NAD+ as a universal viability reagent.
Lnc21q22.11 Suppresses Gastric Cancer via MEK/ERK
2026-09-02
The 2025 reference study identifies Lnc21q22.11 as a 1,202-nucleotide long non-coding RNA that is reduced in gastric cancer and restrains tumor-associated cell behaviors. Its interaction with MYH9 links histone-regulated lncRNA expression to inhibition of MEK/ERK signaling, providing a mechanistic basis for further biomarker and therapeutic research.
AZD6482 as a Context-Aware PI3Kβ Probe
2026-09-02
AZD6482 is a selective PI3Kβ inhibitor with applications in platelet, metabolic, and pathway-focused research. This article explains how to interpret its biology alongside RNA-foci assay principles from recent DM1 research without conflating distinct experimental systems.
NeuroD1–GPX4 Signaling and Ferroptosis Resistance
2026-09-01
The reference study identifies NeuroD1 as a transcriptional regulator of GPX4 that protects hepatocellular carcinoma cells from lipid-peroxidation-driven ferroptosis. Its combined genetic, biochemical, transcriptional, and in vivo evidence connects NeuroD1–GPX4 signaling to tumorigenic potential and suggests a mechanism for improving ferroptosis-oriented cancer research.
PGF2α/PTGFR in Endometrial Breakdown and Vascular Dynamics
2026-09-01
This 2024 mouse menstrual-like model study identifies PGF2α/PTGFR as a major regulator of endometrial breakdown through changes in vascular permeability and angiogenic balance. It further shows that HIF-1α directly regulates Ptgfr transcription, connecting progesterone withdrawal, hypoxia-related signaling, and tissue remodeling in a mechanistically coherent pathway.
MK-1775 Workflow for Wee1 Kinase Studies
2026-08-31
Use MK-1775 to connect Wee1 inhibition with CDC2 Tyr15 dephosphorylation, G2 checkpoint override, and chemotherapy sensitization in carefully designed cancer cell assays. This workflow separates growth arrest from true cell killing so apparent drug responses are easier to interpret and reproduce.
Imipenem at the Neuroimmune Interface
2026-08-30
Imipenem is a semisynthetic thienamycin antibiotic with a distinctive opportunity in spatially resolved antibacterial research. This article connects PBP-directed bactericidal activity and immune response modulation with therapeutic-releasing intracortical probe assays while defining the limits of current evidence.
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-29
Track both mRNA uptake and functional EGFP expression in one experiment with a Cap1, 5-moUTP reporter. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is especially useful for comparing macrophage-targeted nanoparticles, separating delivery from translation failure, and optimizing quantitative gene-transfer assays.
461 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page